Vaccines Manufacturing and Innovation Centre
(asked on 20th January 2021) - View Source
Question to the Department for Business, Energy and Industrial Strategy:
To ask Her Majesty's Government whether their investment in the rapid deployment facility for COVID-19, announced on 17 May 2020, has been allocated; and whether the facility is operational.
Answered by
Lord Callanan
Parliamentary Under Secretary of State (Department for Energy Security and Net Zero)
The £38 million investment announced on 17 May 2020 has since been revised because it was superseded following supply agreements with vaccine candidates. Therefore, the costs were limited to the equipment and the knowledge transfer. The Government has committed £8.75 million towards the rapid deployment facility which is now operational and manufacturing the University of Oxford/AstraZeneca vaccine.